Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2024

Genmab — Januar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #1193

    Genmab-partner har stor vækst i Kesimpta-salget https://www.proinvestor.com/investornyt/1110393/genmab-partner-har-stor-vaekst-i-kesimpta-salget

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #1194

      @ 08.46 -it means at a minimum that they perceive their ADC to be better then their bispecific, but i don't think we have seen data on either, so not sure how high the bar has been set.... that PF-07260437 stopped recruiting isn't really news, we mentioned it here a few months ago

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #1195

        that is news @Hen , this is the same from JNJ https://www.jnj.com/johnson-johnson-submits-supplemental-biologics-license-application-to-u-s-fda-seeking-approval-of-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-based-regimen-for-the-treatment-of-patients-with-transplant-eligible-newly-diagnosed-multiple-myeloma

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #1196

          Hvad er et realistisk potentiale for B-cell terapi i MS. Hvis Kesi pt har ca. 55-60% af B-cell terapi i MS, men kun 1/3 af pt. er på B-cell terapi.

          1 Reply Last reply
          0
          • L Offline
            L Offline
            lahn1
            wrote on sidst redigeret af
            #1197

            Hvad kan vi så forvente af peak Kesimpta sales ?

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #1198

              08:25 USD 4bn according to novartis

              1 Reply Last reply
              0
              • L Offline
                L Offline
                lahn1
                wrote on sidst redigeret af
                #1199

                Thx, so up to 40% of all MS pt. on Kesi 😮

                1 Reply Last reply
                0
                • R Offline
                  R Offline
                  Riis7
                  wrote on sidst redigeret af
                  #1200

                  Hvad siger TA, er det snart tid til køb, man kan jo ta lidt profit fra Novo 😉

                  1 Reply Last reply
                  0
                  • R Offline
                    R Offline
                    Riis7
                    wrote on sidst redigeret af
                    #1201

                    FA virker ikke Genmab pt

                    1 Reply Last reply
                    0
                    • K Offline
                      K Offline
                      kkjoel
                      wrote on sidst redigeret af
                      #1202

                      Flot iagttagelse.

                      1 Reply Last reply
                      0
                      • K Offline
                        K Offline
                        kkjoel
                        wrote on sidst redigeret af
                        #1203

                        Keep them coming - the Goldkorns!

                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          kkjoel
                          wrote on sidst redigeret af
                          #1204

                          Og for at svare på dit spørgsmål: JA. Det er NU du skal købe Genmab. Heeelt klar på TA. Måske. Men det kan godt være den falder lidt - eller måske - meget mere. Dog stadigvæk.

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Riis7
                            wrote on sidst redigeret af
                            #1205

                            Goldkorns are not, there is not much compounding in Genmab at the moment 🙂 respect for all your work and time you spend on Genmab EL, do you have other shares than Genmab and biotec
                            shares?:-)

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bikube
                              wrote on sidst redigeret af
                              #1206

                              "Lundbech slår ikke placebo med middel fra Genmabsamarbejdet" siger MedWatch

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #1207

                                they will have a conf call in 30 mins on it , via

                                • Lundbeck announces supportive phase II results with Lu AF82422 in the treatment of Multiple System Atrophy from the AMULET trial https://news.cision.com/h--lundbeck-a-s/r/lundbeck-announces-supportive-phase-ii-results-with-lu-af82422-in-the-treatment-of-multiple-system-a,c3920120
                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  Bella1
                                  wrote on sidst redigeret af
                                  #1208

                                  Riis, du ser på hullerne i osten, - elsker dem ligefrem? Det er OSTEN det handler om, og den lagres som den skal. Var der forresten ikke noget om , at du solgte din ost, og ville genkøbe omkring de 1600? I så fald tror jeg du må nøjes med ris...;-)

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    gdn55
                                    wrote on sidst redigeret af
                                    #1209

                                    God beskrivelse Bella 1

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gentogen
                                      wrote on sidst redigeret af
                                      #1210

                                      Jeg kom lidt sent på, men de lyder jo ret optimistiske: "deinititely slowing progression" med "the only dataset in thje world" og "many, many,possibilities" og "important for the company" (men jeg hørte ikke det første og vigtigste)

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #1211

                                        yea, i am a bit confused, when i first read ' no statistically significant difference between Lu AF82422 and placebo ' , i thought study failure, but they sound optimistic indeed and keen on talking to regulators to start registrational trials

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #1212

                                          Kesimpta er outstanding og gør virkelig en forskel for RRMS petiemter. Bedre kan det ikke gøres !

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper